Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)

Multidisciplinary Respiratory Medicine

Volumn 10, Issue 1, 2015, Pages

  Dal Negro, Roberto W ^a,c   Bonadiman, Luca ^a   Bricolo, Fernanda P ^a   Tognella, Silvia ^b   Turco, Paola ^c  

^a National Centre of Studies of Pharmacoeconomics and Respiratory Pharmacoepidemiology (CESFAR)   (Italy)

^b Research and Clinical Governance   (Italy)

^c Orlandi General Hospital   (Italy)

Author keywords

Cognition impairment; COPD; Long term oxygen treatment; Severe chronic obstructive pulmonary disease

Indexed keywords

AGED; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOCK DRAWING TEST; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DETERIORATION; FEMALE; HOME OXYGEN THERAPY; HUMAN; HYPOXEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PSYCHOMETRY; RISK FACTOR; TRAIL MAKING TEST A; TRAIL MAKING TEST B;

EID: 84951052035     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/s40248-015-0013-4     Document Type: Article

References (36)

1. Vestbo J, Hurd S, Agusti A.G., Jones PW, Vogelmeier C, Anzueto A, et al Global Strategy for the diagnosis, management and prevention of COPD: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65.
2. Sullivan SD, Ramsey SD, Lee TA The economic burden of COPD. Chest. 2000;117(2 Suppl):5s-9.
3. Chapman KR, Mannino DM, Soriano J.B., Vermeire PA, Buist AS, Thun MJ, et al Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188-207.
4. Ait-Khaled N., Enarson DA, Ottmani S, El Sony A, Eltigani M, Sepulveda R. Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis. 2007;2(2):141-50.
5. Eisner MD, Blanc PD, Yelin E.H., Sidney S., Katz PP, Ackerson L, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121(9):789-96.
6. Calverly PM. Neuropsycological deficits in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1996;51(1):5-6.
7. Ambrosino N, Bruletti G, Scala V., Porta R, Vitacca M. Cognitive and perceived health status in patients with chronic obstructive pulmonary disease surviving acute or chronic respiratory failure: a controlled study. Intensive Care Med. 2002;28(2):170-7.
8. Antonelli-Incalzi C., Corsonello A, Troiano L., Pedone C, Acanfora D, Spada A., et al. Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord. 2007;23(4):264-70.
9. Dodd JW, Getov SV, Jones W. Cognitive function in COPD. Eur Respir J. 2010;35(4):915-22.
10. Semenza C, Mondini S, Borgo F., Pasini M, Sgaramella MT. Proper names in patients with early Alzheimer's disease. Neurocase. 2003;9(1):63-9.
11. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000; 355(9199):225-8.
12. Grant I, Heaton RK, McSweeny AJ Neurophysiological findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:1470-6.
13. Krzyzanowski M, Jedrichowski W, Wysocki M. Factors associated with the change in ventilator function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study. Am Rev Respir Dis. 1986;134(5):1011-9.
14. Kuller LH, Ockene JK, Towsend M. The epidemiology of pulmonary function and COPD mortality in the Multiple Risk Factor Intervention Trial. Am Rev Respir Dis. 1989;140(3):S76-81.
15. Chyou PH, White LR, Yano K, Sharp D.S., Burchfiel CM, Chen R, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol. 1996;143(8):750-6.
16. Incalzi RA, Bellia V, Maggi S., Imperiale C, Capparella O, Catalano F., et al. Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction. Aging Clin Exp Res. 2002;14(5):395-401.
17. Petersen RC, Stevens JC, Ganguli M, Tangalos E.G., Cummings JL, DeKosky ST. Practice Parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Accademy of Neurology. Neurology. 2001;56(9):1133-42.
18. Isoaho R, Puolijoki H, Huhti E., Laippala P, Kivela SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996;8(1):113-25.
19. Kozora E, Filley CM, Julian L.J., Cullum CM. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(3):178-83.
20. Petersen RC, Smith GE, Waring S.C., Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8.
21. Huppert FA. Memory impairment associated with chronic hypoxia. Thorax. 1982;37(11):858-60.
22. Dal Negro R.W., Bonadiman L, Tognella S., Bricolo FP, Turco P. Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Chron Obstruct Pulmon Dis. 2014;9:675-83.
23. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2012. Available from: http://www.goldcopd.org/Guidelines/guidelines-global-strategy-for-diagnosis-management-2012.html. Accessed December 10, 2014.
24. Jones PW, Harding G, Berry P., Wiklund I, Chen WH, Kline Leikly N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
25. Dal Negro R.W., Bonadiman L, Turco P. Sensitivity of the COPD Assessment Test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic. The first Italian specific study. Multidiscip Resp Med. 2014;9:15-22.
26. Bestall JC, Paul EA, Garrod R, Garnham R., Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-6.
27. Charlson ME, Pompei P, Ales K.L., MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
28. Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practica method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
29. Brown EC, Casey A, Fisch R.I., Neuringer C Trial making test as a screening device for the detection of brain damage. J Consult Psychol. 1958;22:469-74.
30. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M., Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17(4)305-9.
31. Qian H, Lin H, Li Y. Assessment of cognition and associated factors in patients with stable chronic obstructive pulmonary disease. Zohngua Jie He He Hu Xi Za Zhi. 2014;37:769-73
32. Fujimoto S, Kobayashi S, Yoshikawa T., Hirata K. Cognitive function in patients with chronic obstructive pulmonary disease. Nihon Rinsho. 2014;72:721-5.
33. Gagnon K, Baril AA, Gagnon J.F., Fortin M., Decary A, Lafond C, et al Cognitive impairment in obstructive sleep apnea. Pathol Biol. 2014;62:233-40.
34. Pleis JR, Leithbridge-Cejku M. Summary Health Statistics for U.S. adults. National Health Interview Survey. 2006. Vital Health Stat. 2007;10:20-3.
35. Anstey KJ, Windsor TD, Jorm AF Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004;50(4):230-4.
36. Hjalmarsen A, Waterloo K, Dahl A., Jorde R, Viitanen M. Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol. 1999;42:27-35.